US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist
  • 11.660
  • 0.0000.00%
Close Nov 22 16:00 ET
  • 11.660
  • 0.0000.00%
Post 16:20 ET
1.12BMarket Cap-15546P/E (TTM)

Avadel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avadel Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
48.63M
50.03M
+1.40M
Beat Est.
+593.32%
+613.22%
+2.87%
EPS
-0.06
-0.03
+0.03
Beat Est.
+85.39%
+92.68%
+49.92%
Analyst Rating
Strong Buy

Nov 19, 2024

Avadel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 58.711M--
--2024/Q4-- / 52.696M--
Nov 12, 20242024/Q350.025M / 48.629M--
Aug 8, 20242024/Q241.504M / 37.579M--
May 8, 20242024/Q127.178M / 25.896M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 58.711M--
--2024/Q4-- / 52.696M--
Nov 12, 20242024/Q350.025M / 48.629M--
Aug 8, 20242024/Q241.504M / 37.579M--
May 8, 20242024/Q127.178M / 25.896M--

Unlock Free Earnings Estimates

Avadel Pharmaceuticals Earnings Reports

  • Avadel Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 09:39 ET

  • Avadel Pharmaceuticals | 8-K: Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

    Nov 12 09:30 ET

  • Avadel Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 09:29 ET

  • Avadel Pharmaceuticals | 8-K: Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results

    Aug 8 07:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 19, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data